For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Morphic Therapeutic, Inc.

USPTO Granted Patents = 15

EPO Patents = 4

Trademarks = 2

Forward Citations = 44

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Fu-Yang Lin (15 out of 15 patents)

Blaise S Lippa (15 out of 20 patents)

Dawn M Troast (15 out of 15 patents)

4. Aleksey I Gerasyuto (15 out of 23 patents)

5. Bruce Nelsen Rogers (15 out of 47 patents)

6. Matthew Gregory Bursavich (15 out of 22 patents)

7. Bryce Alden Harrison (15 out of 19 patents)

8. Kristopher N Hahn (14 out of 14 patents)

9. Kyle D Konze (14 out of 14 patents)

10. Mats A Svensson (12 out of 12 patents)

11. Alexey Alexandrovich Lugovskoy (10 out of 50 patents)

12. Cheng Zhong (8 out of 12 patents)

13. Byungchan Kim (7 out of 8 patents)

14. Tyler Day (7 out of 7 patents)

15. Brian Sosa (6 out of 6 patents)

15 patents: Sort by Forward Citations

1. 12459942 - Inhibiting (α-v)(β-6) integrin (2025-11-04),

2. 12415796 - Inhibitors of (αv)(β6) integrin (2025-09-16),

3. 12221416 - Antagonists of human integrin α4β7 (2025-02-11),

4. 12145935 - Inhibitors of (α-v)(β-6) integrin (2024-11-19),

5. 11827621 - Inhibitors of (α-v)(β-6) integrin (2023-11-28),

6. 11795167 - Inhibitors of (α-v)(β-6) integrin (2023-10-24),

7. 11739087 - Inhibiting (α-v)(β-6) integrin (2023-08-29),

8. 11370773 - Inhibiting human integrin (alpha-4) (beta-7) (2022-06-28),

9. 11174228 - Antagonists of human integrin (α4)(β7) (2021-11-16),

10. 11104661 - Inhibiting human integrin (α-4) (β-7) (2021-08-31),

11. 11046685 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),

12. 11046669 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),

13. 11040955 - Inhibitors of (alpha-v)(beta-6) integrin (2021-06-22),

14. 11021480 - Inhibiting (α-V)(β-6) integrin (2021-06-01),

15. 10759756 - Antagonists of human integrin α4β7 (2020-09-01),

Morphic Therapeutic, Inc. is a biotechnology company that focuses on developing oral integrin therapies for serious chronic diseases. The company's proprietary platform enables the discovery and optimization of small molecule integrin inhibitors, providing novel treatment options for patients. With a strong pipeline and cutting-edge research, Morphic Therapeutic is dedicated to transforming the field of integrin biology and advancing personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#80 in Waltham, MA

#1,231 in Massachusetts

#20,434 in US

#38,722 in the World

Waltham, MA, United States of America

Morphic Therapeutic, Inc.

Forward Citations = 44

24 inventors:

Fu-Yang Lin (15 out of 15 patents)

Blaise S Lippa (15 out of 20 patents)

Dawn M Troast (15 out of 15 patents)

4. Aleksey I Gerasyuto (15 out of 23 patents)

5. Bruce Nelsen Rogers (15 out of 47 patents)

Please report any incorrect information to support@idiyas.com

Loading…